“Developing an Effective Patenting Policy to Protect AI-Enabled Medical Devices”

October 7, 2024
Med Device Online

Marshall Gerstein Partner and patent attorney Ryan Phelan provides insight for medical device leaders as they embrace artificial intelligence (AI) to revolutionize the industry. In a column for Med Device Online, Ryan explores how to develop an effective patenting policy for protecting AI-powered medical devices, focusing on the FDA's evolving stance on patent eligibility and patent marking requirements.

“AI’s role in software-based medical devices, ranging from diagnostics to treatment plans, is rapidly growing,” Phelan notes. “As these innovations emerge, protecting intellectual property (IP), particularly through patents becomes critical. A well-defined AI policy is essential to safeguard these medical devices from infringement while encouraging further innovation.”

You may read Ryan’s article in Med Device Online here.

Offsite Notice

By clicking “Proceed” below, you will be opening a new browser window and leaving our website.